導管市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品類型、最終用途、地區和競爭細分，2020-2030 年

2024 年全球導管市場價值為 584.5 億美元，預計到 2030 年將達到 802.7 億美元，預測期內的年複合成長率(CAGR) 為 5.39%。近年來，由於慢性病發病率不斷上升、全球人口老化以及醫療技術的進步，市場經歷了顯著成長。導管是用於各種應用的重要醫療設備，包括心血管、泌尿科、神經血管和靜脈手術。它們在醫院、門診手術中心和家庭醫療保健機構的廣泛使用促進了這種擴展。此外，人們對微創手術的認知不斷提高，加速了對創新導管技術的需求。

推動導管市場成長的一個主要因素是心血管疾病（CVD）和泌尿系統疾病發生率的上升。心血管導管，例如血管攝影導管和電生理導管，廣泛用於心臟病的診斷和治療。同樣，導尿管對於患有尿失禁和其他膀胱相關問題的患者（尤其是老年患者）來說是必不可少的。慢性病發生率不斷上升，加上外科手術數量的不斷增加，預計將維持對導管的需求。

導管設計和材料的技術進步是擴大市場的關鍵。抗菌塗層和藥物洗脫導管的發展大大降低了與導管插入相關的感染風險。此外，配備即時監控感測器的智慧導管的出現提高了患者的安全性和治療效果。製造商也專注於生物相容性材料，以增強導管的耐用性和性能，使其更適合患者。

主要市場促進因素

慢性病盛行率上升

住院和手術次數增加

主要市場挑戰

定價壓力和報銷問題

供應鏈中斷和材料短缺

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：COVID-19 對全球導管市場的影響

第5章：全球導管市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依產品類型（心血管導管（電生理導管、PTCA 球囊導管、IVUS 導管、PTA 球囊導管）、泌尿科導管（血液透析導管、腹膜導管、Foley 導管、間歇導管、外部導管）、靜脈導管（外周導管、中線外周導管、中心靜脈導管）、神經血管導管（特種導管、傷口/手術導管、血導管、熱導管
  • 依最終用途（醫院商店、零售店、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美導管市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第 7 章：歐洲導管市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 8 章：亞太導管市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 韓國
  • 日本
  • 澳洲

第 9 章：南美導管市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲導管市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如果有）
• 最新動態

第 13 章：全球導管市場：SWOT 分析

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• Edward Lifesciences
• Smith Medical Inc.
• Teleflex Incorporated
• ConvaTec Group Plc
• Cure Medical LLC
• Terumo Corporation
• Cook Medical Inc.

第 16 章：策略建議

第17章 關於出版商,免責事項

The global catheter market was valued at USD 58.45 billion in 2024 and is projected to reach USD 80.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.39% during the forecast period. The market has experienced significant growth in recent years, driven by the increasing prevalence of chronic diseases, an aging global population, and advancements in medical technology. Catheters are vital medical devices used in a variety of applications, including cardiovascular, urology, neurovascular, and intravenous procedures. Their widespread use across hospitals, ambulatory surgical centers, and home healthcare settings has contributed to this expansion. Furthermore, rising awareness of minimally invasive procedures has accelerated demand for innovative catheter technologies.

A major factor driving growth in the catheter market is the rising incidence of cardiovascular diseases (CVDs) and urinary disorders. Cardiovascular catheters, such as angiography and electrophysiology catheters, are widely used in the diagnosis and treatment of heart conditions. Similarly, urinary catheters are essential for patients with urinary incontinence and other bladder-related issues, particularly in the elderly. The increasing prevalence of chronic diseases, coupled with the rising number of surgical procedures, is expected to sustain the demand for catheters.

Technological advancements in catheter design and materials have been key in expanding the market. The development of antimicrobial-coated and drug-eluting catheters has significantly reduced infection risks associated with catheterization. Additionally, the emergence of smart catheters, equipped with sensors for real-time monitoring, has improved patient safety and treatment outcomes. Manufacturers are also focusing on biocompatible materials to enhance the durability and performance of catheters, making them more patient-friendly.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global catheter market is experiencing strong growth, largely driven by the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, urinary incontinence, and neurological conditions. These diseases often require continuous treatment, surgical procedures, and hospital care, with catheters playing a crucial role in patient management. Additionally, the growing geriatric population, technological advancements in catheter design, and the expansion of healthcare infrastructure worldwide have further increased demand for these devices.

Cardiovascular diseases (CVDs) are a leading cause of death globally, with conditions such as coronary artery disease, heart failure, and arrhythmias requiring catheter-based interventions. According to the World Health Organization (WHO), CVDs cause approximately 17.9 million deaths annually, underscoring the need for advanced cardiac treatments. Catheters are crucial in procedures such as angioplasty, electrophysiology studies, and cardiac catheterization. As minimally invasive techniques gain popularity, the demand for advanced cardiovascular catheters, including balloon catheters, electrophysiology catheters, and guiding catheters, has increased. The growing number of catheter-based cardiac ablation procedures to treat atrial fibrillation further boosts market demand. Moreover, innovations like steerable catheters and bioresorbable stents have enhanced the efficacy of catheter-based cardiac interventions.

Diabetes is another significant driver of catheter demand, as the condition is associated with various complications, such as kidney disease, neuropathy, and urinary retention, which often require catheter interventions. The International Diabetes Federation (IDF) estimates that over 537 million adults were living with diabetes in 2021, with the number expected to reach 783 million by 2045. For diabetic patients with end-stage renal disease (ESRD), hemodialysis is a critical treatment, requiring the use of tunneled and non-tunneled dialysis catheters. Furthermore, insulin pump therapy, which uses catheter-based infusion sets, is becoming more popular for better glycemic control, contributing to market growth.

Urinary incontinence and other bladder disorders are increasingly common, particularly among the aging population. Conditions such as benign prostatic hyperplasia (BPH), neurogenic bladder, and spinal cord injuries often necessitate catheterization for urine drainage. Foley catheters, intermittent catheters, and external catheters are commonly used for managing urinary retention and incontinence. The aging population is a major factor driving the growing demand for urinary catheters. According to the United Nations, the number of individuals aged 65 and older is expected to double by 2050, reaching 1.5 billion. As age-related urological disorders become more prevalent, the need for long-term catheter use in home healthcare settings is increasing. Additionally, the rising acceptance of self-catheterization for greater patient independence is accelerating market growth.

Increasing Hospitalizations and Surgical Procedures

The global catheter market is also expanding due to the rising number of hospitalizations and surgical procedures. Catheters are essential medical devices used in numerous diagnostic and therapeutic applications, making them indispensable in modern healthcare. The growing prevalence of chronic diseases, combined with advancements in medical technology, has significantly increased catheter demand. As healthcare providers aim to improve patient outcomes and minimize complications, the catheter market is set for continued growth.

The World Health Organization (WHO) reports that millions of people undergo surgical procedures annually, with surgery contributing to approximately 13% of global disability-adjusted life years (DALYs). An important driver of market growth is the increasing number of surgical interventions across various medical specialties. CVDs, a leading cause of global mortality, often require frequent catheter-based medical interventions. Procedures such as angioplasty, stent placement, and electrophysiology studies rely heavily on the use of cardiovascular catheters. The increasing incidence of heart diseases, driven by factors like aging populations, sedentary lifestyles, and poor dietary habits, has led to a higher number of cardiac surgeries and catheter-based treatments.

Key Market Challenges

Pricing Pressure and Reimbursement Issues

The catheter market is highly competitive, resulting in significant pricing pressures among manufacturers. Healthcare providers and governments, especially in cost-sensitive regions, are demanding lower prices for medical devices, which erodes profit margins for companies. Furthermore, reimbursement policies vary across countries, impacting the affordability of catheters for patients. In some regions, limited insurance coverage or restrictive reimbursement policies may reduce accessibility to advanced catheter technologies, hindering market growth.

Supply Chain Disruptions and Material Shortages

The global supply chain for medical devices, including catheters, has been significantly disrupted by geopolitical tensions, trade restrictions, and logistical bottlenecks. The COVID-19 pandemic exposed vulnerabilities in supply chains, leading to shortages of essential raw materials such as silicone, latex, and polyurethane, which are critical in catheter manufacturing. These disruptions have resulted in increased production costs and delays in product availability, affecting both manufacturers and healthcare providers.

Key Market Trends

Technological Advancements

The catheter market is experiencing substantial growth driven by rapid technological innovations. Advances in catheter materials, design, and functionality are enhancing patient comfort, reducing infection risks, and improving overall procedural efficiency. Key innovations include the development of antimicrobial coatings, hydrophilic surface modifications, and the use of biocompatible materials like silicone and polyurethane, which have improved flexibility, durability, and compatibility with the human body. These advancements make catheters more effective and patient-friendly, further driving market expansion.

Key Market Players

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• Edwards Lifesciences
• Smith Medical Inc.
• Teleflex Incorporated
• ConvaTec Group Plc
• Cure Medical LLC
• Terumo Corporation
• Cook Medical Inc.

Report Scope

This report provides a detailed analysis of the global catheter market, segmented into the following categories:

• Product Type: Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, Specialty Catheters.
• End-Use: Hospital Stores, Retail Stores, Others.
• Region: North America (United States, Canada, Mexico), Europe (France, United Kingdom, Italy, Germany, Spain), Asia Pacific (China, India, Japan, Australia, South Korea), South America (Brazil, Argentina, Colombia), Middle East & Africa (South Africa, Saudi Arabia, UAE).

Competitive Landscape

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Catheter Market

5. Global Catheter Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Cardiovascular Catheters( Electrophysiology Catheters, PTCA Balloon Catheters, IVUS Catheters, PTA Balloon Catheters), Urology Catheters (Hemodialysis Catheters, Peritoneal Catheters, Foley Catheters, Intermittent Catheters, External Catheters), Intravenous Catheters( Peripheral Catheters, Midline Peripheral Catheters, Central Venous Catheters), Neurovascular Catheters (Specialty Catheters, Wound/Surgical Catheters, Oximetry Catheters, Thermodilution Catheters, IUI Catheters)
  • 5.2.2. By End Use (Hospital Stores, Retail Stores, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Catheter Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Catheter Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Catheter Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Catheter Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End Use

7. Europe Catheter Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Catheter Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Catheter Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Catheter Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Catheter Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Catheter Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End Use

8. Asia Pacific Catheter Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Catheter Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Catheter Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Catheter Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Catheter Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Catheter Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End Use

9. South America Catheter Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Catheter Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Catheter Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Catheter Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Catheter Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Catheter Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Catheter Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Catheter Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Catheter Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Hollister Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Medtronic PLC
• 15.3. Boston Scientific Corporation
• 15.4. Edward Lifesciences
• 15.5. Smith Medical Inc.
• 15.6. Teleflex Incorporated
• 15.7. ConvaTec Group Plc
• 15.8. Cure Medical LLC
• 15.9. Terumo Corporation
• 15.10. Cook Medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer